Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Cohen–Boyer recombinant DNA patents | Statement: [Stanley N. Cohen, knownFor, Cohen–Boyer recombinant DNA patents]

Target entity: Cohen–Boyer recombinant DNA patents
Context triple: [Stanley N. Cohen, knownFor, Cohen–Boyer recombinant DNA patents]

• A. Bayh–Dole Act
  The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
• B. Technical Corrections to the Bayh–Dole Act
  Technical Corrections to the Bayh–Dole Act is a legislative measure that refined and clarified the original Bayh–Dole Act’s provisions governing the ownership and commercialization of inventions arising from federally funded research.
• C. CRISPR-Cas9 gene-editing technology
  CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
• D. Association for Molecular Pathology v. Myriad Genetics, Inc.
  Association for Molecular Pathology v. Myriad Genetics, Inc. is a landmark 2013 U.S. Supreme Court case that held naturally occurring human genes cannot be patented, reshaping the legal landscape for biotechnology and genetic testing.
• E. Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure
  The Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure is an international agreement that standardizes how deposits of microorganisms are recognized for patent applications, allowing a single deposit at an approved authority to be accepted by all member states.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Cohen–Boyer recombinant DNA patents
Triple: [Stanley N. Cohen, knownFor, Cohen–Boyer recombinant DNA patents]

The Cohen–Boyer recombinant DNA patents were foundational biotechnology patents that covered key methods for creating recombinant DNA, enabling modern genetic engineering and the biotechnology industry.

Target entity: Cohen–Boyer recombinant DNA patents
Target entity description: The Cohen–Boyer recombinant DNA patents were foundational biotechnology patents that covered key methods for creating recombinant DNA, enabling modern genetic engineering and the biotechnology industry.

• A. Bayh–Dole Act
  The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
• B. Technical Corrections to the Bayh–Dole Act
  Technical Corrections to the Bayh–Dole Act is a legislative measure that refined and clarified the original Bayh–Dole Act’s provisions governing the ownership and commercialization of inventions arising from federally funded research.
• C. CRISPR-Cas9 gene-editing technology
  CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
• D. Association for Molecular Pathology v. Myriad Genetics, Inc.
  Association for Molecular Pathology v. Myriad Genetics, Inc. is a landmark 2013 U.S. Supreme Court case that held naturally occurring human genes cannot be patented, reshaping the legal landscape for biotechnology and genetic testing.
• E. Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure
  The Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure is an international agreement that standardizes how deposits of microorganisms are recognized for patent applications, allowing a single deposit at an approved authority to be accepted by all member states.
• F. None of above. chosen